Inhalation Anesthetics Market Will Touch USD 2,144.6 Million by 2030

According to the latest market research study published by P&S Intelligence, the inhalation anesthetics market will advance at a 5.2% compound annual growth rate, to touch USD 2,144.6 million, by 2030.

The growth of the industry is attributed to the mounting utilization of inhalation anesthetic medications, because of the rising cases of trauma, surging elderly population prone to chronic illnesses, and increasing health services and surgeries accessibility.

Download sample copy of this report: https://www.psmarketresearch.com/market-analysis/inhalation-anesthetics-market/report-sample

The hospitals category, based on end user, accounted for the largest share, and it will further advance at a 5.6% CAGR in the years to come. The medications benefit surgeons by preventing additional patients' hospital stays due to the minimum number of MAC of these medications.

The sevoflurane category, based on drug type, accounted for the largest inhalation anesthetics market share, in recent years, and it will further advance at a 5.1% CAGR in the years to come. This is attributed to the fact that sevoflurane is a widely utilized medicine for anesthesia, because of its therapeutic features. Moreover, it is an ether inhalation anesthetic agent with low pungency, low blood-gas partition coefficient, and non-irritant odor.

The APAC inhalation anesthetics industry will observe the fastest growth in the years to come. This is attributed to the mounting population, increasing acceptance of new technologies in surgeries, rising healthcare spending per capita, and growing investments in healthcare infrastructure in the region.

Browse detailed analysis of this report: https://www.psmarketresearch.com/market-analysis/inhalation-anesthetics-market

Furthermore, the requirement for these drugs has surged due to government-favored reimbursement systems and their adoption in both private and public healthcare establishments.

With the growing accessibility to surgeries & health, as well as the surging elderly population prone to chronic illnesses, the inhalation anesthetics industry will continue to advance in the years to come.

Inhalation Anesthetics Market Size Breakdown by Segment

By Drug Type
• Desflurane
• Sevoflurane
• Isoflurane
• Others
By End User
• Hospitals
• Ambulatory Surgical Centers
• Others
By Application
• Induction
• Maintenance
By Region
• North America Inhalation Anesthetics Market
o By Drug Type
o By End User
o By application
o By country - U.S. and Canada
• Europe Inhalation Anesthetics Market
o By Drug Type
o By End User
o By application
o By country - France, Germany, Italy, Spain, U.K., and Rest of Europe
• Asia-Pacific (APAC) Inhalation Anesthetics Market
o By Drug Type
o By End User
o By application
o By country - China, India, Japan, South Korea, Australia, and Rest of APAC
• Latin America (LATAM) Inhalation Anesthetics Market
o By Drug Type
o By End User
o By application
o By country - Brazil, Mexico, and Rest of LATAM
• Middle East and Africa (MEA) Inhalation Anesthetics Market
o By Drug Type
o By End User
o By application
o By country - Saudi Arabia, South Africa, and Rest of MEA

Contact:
Chandra Mohan
AVP - Business Development
Phone: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
Blog: https://www.psmarketresearch.com/blogs

About P&S Intelligence

P&S Intelligence offers custom and syndicated market research and consulting services to clients across the globe. Our team of young and dynamic researchers, guided by mentors with years of experience, create data-rich reports tailored to the needs of MNCs as well as startups and SMEs. We remain in a perennial quest to offer exhaustive insights into every aspect of the market, allowing businesses of all sizes to seize even the smallest of opportunities and tackle even the biggest of challenges.

This release was published on openPR.